Eculizumab Successfully Rescues Against de novo Atypical Hemolytic Uremic Syndrome Following Retransplantation. Li M, Wen J, Dong J, Wen N, et al. Transplant Proc 2026;58:460-465.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li M, Wen J, Dong J, Wen N, et al. Eculizumab Successfully Rescues Against de novo Atypical Hemolytic Uremic Syndrome Following Retransplantation. Transplant Proc 2026;58:460-465.
PMID: 41765707